ARPU

Moving beyond advice, Rain's new AI financial agent takes action to stabilize cash flow and build wealth, but it raises new questions about trust.

100 Teamsters at Atlanta's airport secured major wage hikes and benefits, a victory that could ripple through the entire rental car industry.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

As AI pushes data centers to their limits, the optical industry gathers at OFC 2026 to unveil the power-efficient, high-speed networks of the future.

Restaurant Brands International reports strong 2025 results, fueled by booming international sales, but faces headwinds with Popeyes' slump and BK franchisee pressures.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A spike in layoffs to 14-year highs clashes with extreme investor optimism, raising fears of a major market correction on the horizon for 2026.

A new bond issue strengthens Agilyx's finances, funding a dual strategy focused on immediate earnings and long-term tech licensing in plastic recycling.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

A new report reveals a grim reality: the typical American worker has under $1,000 for retirement. Is the system, not the saver, fundamentally broken?

IUOE Local 150 backs Speaker Welch for State Central Committeeperson, signaling a major power play in Illinois Democratic politics post-Danny Davis.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

A new initiative from the Center for Educational Innovation aims to tackle the workforce readiness gap with AI, robotics, and teacher leadership training.